SYRA (Syra Health) Payments of Debt: $-0.32 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SYRA Syra Health Corp SYRA
12 GF Score
Price $0.70
GF Value $0.23
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Syra Health Payments of Debt?

Syra Health SYRA +7.39% 12 Payments of Debt is $-0.32 Mil as of Mar. 2026. GuruFocus rates SYRA with a GF Score™ of 12/100 and a GF Value™ of $0.23 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Syra Health's Payments of Debt for the three months ended in Mar. 2026 was $-0.05 Mil.

Syra Health's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.32 Mil.

Syra Health Payments of Debt Related Terms

Syra Health Payments of Debt Historical Data

* Premium members only.

The historical data trend for Syra Health's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syra Health Payments of Debt Chart

Syra Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial 0.00 -2.08 -1.24 -0.41 -0.35

Syra Health Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.11 -0.09 -0.07 -0.05
SYRA
12GF Score
Syra Health Corp SYRA
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syra Health Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-0.32 Mil mean?
Syra Health (SYRA) has a Payments of Debt of $-0.32 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Syra Health and its competitors.
Is Syra Health's Payments of Debt too high?
Syra Health's current Payments of Debt is $-0.32 Mil. Overall, Syra Health has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Syra Health's Payments of Debt compare to NIVF and BICX?
Syra Health's Payments of Debt of $-0.32 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Healthcare Providers & Services company?
A good Payments of Debt depends on the Healthcare Providers & Services industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Syra Health and its competitors. Syra Health's current Payments of Debt is $-0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syra Health stock overvalued right now?
Based on GuruFocus' analysis, Syra Health (SYRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.70 — trading 204.4% above its estimated fair value. The current Payments of Debt is $-0.32 Mil. Syra Health's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Syra Health (SYRA), the current Payments of Debt is $-0.32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syra Health (SYRA) Overvalued in 2026?

Based on GuruFocus' analysis, Syra Health stock appears to be overvalued. The current stock price of $0.70 is trading 204.4% above its estimated GF Value™ of $0.23. GuruFocus considers Syra Health to be Significantly Overvalued.

Key valuation signals for SYRA:

  • Payments of Debt: $-0.32 Mil
  • GF Value™: $0.23 vs. price of $0.70 (204.4% above fair value)
  • GF Score™: 12/100 with 2 warning signs

No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syra Health Business Description

Address 1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
12GF Score

Get the complete analysis for SYRA

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.70
Price
$0.23
GF Value